Umbilical cord mesenchymal stromal cells as critical COVID‐19 adjuvant therapy: A randomized controlled trial

Umbilical cord mesenchymal stromal cells as critical COVID‐19 adjuvant therapy: A randomized controlled trial

Abstract One of the main causes of acute respiratory distress syndrome in coronavirus disease 2019 (COVID‐19) is cytokine storm, although the exact cause is still unknown. Umbilical cord mesenchymal stromal cells (UC‐MSCs) influence proinflammatory T‐helper 2 (Th2) cells to shift to an anti‐inflamma...

Full description

Bibliographic Details
Main Authors: Ismail Hadisoebroto Dilogo, Dita Aditianingsih, Adhrie Sugiarto, Erlina Burhan, Triya Damayanti, Pompini Agustina Sitompul, Nina Mariana, Radiana D. Antarianto, Isabella Kurnia Liem, Tera Kispa, Fajar Mujadid, Novialdi Novialdi, Evah Luviah, Tri Kurniawati, Andri M.T. Lubis, Dina Rahmatika
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Stem Cells Translational Medicine
Subjects:
adjuvants
cord stem cell transplantation
COVID‐19
cytokine release syndrome
immunology
mesenchymal stromal cells
Online Access:https://doi.org/10.1002/sctm.21-0046

Internet

https://doi.org/10.1002/sctm.21-0046

Similar Items